Back |
home / stock / impl / impl message board
Subject | By | Source | When |
---|---|---|---|
Did anyone find-out what the scam was on Friday? | Pedro2004 | investorshub | 09/05/2021 11:19:43 AM |
$IMPL: Wow......... what a kerplunkage. | makinezmoney | investorshub | 09/03/2021 7:39:30 PM |
flipping now easy $ fast sto 1/2 | stock1ace1 | investorshub | 09/03/2021 5:44:49 PM |
34 to 19 how ugly | TheFinalCD | investorshub | 09/03/2021 5:41:03 PM |
I sold those 29's for a profit, then | TheFinalCD | investorshub | 09/03/2021 5:40:10 PM |
looks like the approval was already priced in | stock1ace1 | investorshub | 09/03/2021 5:36:52 PM |
$19.85 gotta love the markets :D may enter soon | stock1ace1 | investorshub | 09/03/2021 5:36:32 PM |
in 29.23 on this big open dip | TheFinalCD | investorshub | 09/03/2021 1:33:21 PM |
$IMPL: NIcely done......... now $35.80 here | makinezmoney | investorshub | 09/03/2021 1:20:42 PM |
Impel NeuroPharma Price Target Announced at $32.00/Share by Guggenheim | crudeoil24 | investorshub | 07/26/2021 1:32:15 AM |
$IMPL buy 10.90 | stocktrademan | investorshub | 07/14/2021 12:59:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Impel Pharmaceuticals Inc. Company Name:
IMPL Stock Symbol:
NASDAQ Market:
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Impel Pharmaceuticals Inc. (IMPL) is expected to report for Q3 2023
2023-10-05 09:39:40 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- Impel Pharmaceuticals Inc. (NASDAQ: IMPL) stated, this morning, that it is exploring strategic alternatives and plans to consider a wide range of options with a focus on maximizing shareholder value, including ...